Melatonin (ilaç) (Turkish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Melatonin (ilaç)" in Turkish language version.

refsWebsite

Global rank Turkish rank

8nih.gov

4^th place

11^th place

8web.archive.org

1^st place

6doi.org

2^nd place

4^th place

2europa.eu

68^th place

79^th place

1surrey.ac.uk

8,396^th place

low place

1books.google.com

3^rd place

5^th place

1ahrq.gov

9,469^th place

low place

1drugs.com

399^th place

156^th place

1canada.ca

1,712^th place

4,961^st place

1hc-sc.gc.ca

low place

1drugbank.ca

4,294^th place

1,705^th place

ahrq.gov

archive.ahrq.gov

"Melatonin for treatment of sleep disorders" (PDF). Evidence Report/Technology Assessment No. 108. (Prepared by the University of Alberta Evidence-based Practice Center, Under Contract No. 290-02-0023.) AHRQ Publication No. 05-E002-2. Rockville, MD: Agency for Healthcare Research and Quality. Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services (108): 1-7. November 2004. doi:10.1037/e439412005-001. PMC 4781368 $2. PMID 15635761. 3 Mayıs 2013 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 5 Haziran 2013. KB1 bakım: göster-yazarlar (link)

books.google.com

ADHD: Non-Pharmacologic Interventions, An Issue of Child and Adolescent Psychiatric Clinics of North America, E-Book. Elsevier Health Sciences. 2014. s. 888. ISBN 978-0-323-32602-5.

canada.ca

"Summary Safety Review – MELATONIN (N-acetyl-5-methoxytryptamine) – Review of the Safety of Melatonin in Children and Adolescents". Government of Canada. Health Canada. 10 Aralık 2015. 13 Haziran 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 9 Ocak 2019.

doi.org

"Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders" (PDF). Sleep Medicine Reviews. 34: 10-22. August 2017. doi:10.1016/j.smrv.2016.06.005. PMID 28648359. 25 Şubat 2021 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 19 Eylül 2023.
"Melatonin for treatment of sleep disorders" (PDF). Evidence Report/Technology Assessment No. 108. (Prepared by the University of Alberta Evidence-based Practice Center, Under Contract No. 290-02-0023.) AHRQ Publication No. 05-E002-2. Rockville, MD: Agency for Healthcare Research and Quality. Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services (108): 1-7. November 2004. doi:10.1037/e439412005-001. PMC 4781368 $2. PMID 15635761. 3 Mayıs 2013 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 5 Haziran 2013. KB1 bakım: göster-yazarlar (link)
"Melatonin and the circadian system: Keys for health with a focus on sleep". Handb Clin Neurol. Handbook of Clinical Neurology. 179: 331-343. 2021. doi:10.1016/B978-0-12-819975-6.00021-2. ISBN 9780128199756. PMID 34225973.
"Melatonin prolonged release: in the treatment of insomnia in patients aged ≥55 years". Drugs & Aging. 29 (11): 911-23. November 2012. doi:10.1007/s40266-012-0018-z. PMID 23044640.
"Comparative Review of Approved Melatonin Agonists for the Treatment of Circadian Rhythm Sleep-Wake Disorders". Pharmacotherapy. 36 (9): 1028-41. September 2016. doi:10.1002/phar.1822. PMC 5108473 $2. PMID 27500861.
"Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery". Pharmacol Rev. 70 (2): 197-245. April 2018. doi:10.1124/pr.117.014381. PMID 29487083.

drugbank.ca

"Melatonin". www.drugbank.ca. 28 Mart 2009 tarihinde kaynağından arşivlendi. Erişim tarihi: 29 Ocak 2019.

drugs.com

"Melatonin: Side Effects, Uses, Dosage (Kids/Adults)". Drugs.com. 18 Haziran 2006 tarihinde kaynağından arşivlendi. Erişim tarihi: 9 Ocak 2019.

europa.eu

ema.europa.eu

Circadin: EPAR - Product Information ANNEX I - SUMMARY OF PRODUCT CHARACTERISTICS. European Medicines Agency (EMA). 2 Şubat 2021. EMEA/H/C/000695 - IA/0066. 4 Ekim 2018 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Eylül 2023.
"Slenyto EPAR". European Medicines Agency (EMA). 17 Eylül 2018. 20 Mart 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 31 Mayıs 2020.

hc-sc.gc.ca

webprod.hc-sc.gc.ca

"Melatonin- Oral". Government of Canada. Health Canada. 28 Ağustos 2018. 1 Nisan 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 9 Ocak 2019.

nih.gov

ncbi.nlm.nih.gov

"Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders" (PDF). Sleep Medicine Reviews. 34: 10-22. August 2017. doi:10.1016/j.smrv.2016.06.005. PMID 28648359. 25 Şubat 2021 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 19 Eylül 2023.
"Melatonin for treatment of sleep disorders" (PDF). Evidence Report/Technology Assessment No. 108. (Prepared by the University of Alberta Evidence-based Practice Center, Under Contract No. 290-02-0023.) AHRQ Publication No. 05-E002-2. Rockville, MD: Agency for Healthcare Research and Quality. Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services (108): 1-7. November 2004. doi:10.1037/e439412005-001. PMC 4781368 $2. PMID 15635761. 3 Mayıs 2013 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 5 Haziran 2013. KB1 bakım: göster-yazarlar (link)
"Insomnia: Pharmacologic Therapy". American Family Physician. 96 (1): 29-35. July 2017. PMID 28671376.
"Management of Insomnia Disorder[Internet]". AHRQ Comparative Effectiveness Reviews. 15 (16): EHC027-EF. 2015. PMID 26844312. Evidence for benzodiazepine hypnotics, melatonin agonists in the general adult population, and most pharmacologic interventions in older adults was generally insufficient KB1 bakım: göster-yazarlar (link)
"Melatonin and the circadian system: Keys for health with a focus on sleep". Handb Clin Neurol. Handbook of Clinical Neurology. 179: 331-343. 2021. doi:10.1016/B978-0-12-819975-6.00021-2. ISBN 9780128199756. PMID 34225973.
"Melatonin prolonged release: in the treatment of insomnia in patients aged ≥55 years". Drugs & Aging. 29 (11): 911-23. November 2012. doi:10.1007/s40266-012-0018-z. PMID 23044640.
"Comparative Review of Approved Melatonin Agonists for the Treatment of Circadian Rhythm Sleep-Wake Disorders". Pharmacotherapy. 36 (9): 1028-41. September 2016. doi:10.1002/phar.1822. PMC 5108473 $2. PMID 27500861.
"Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery". Pharmacol Rev. 70 (2): 197-245. April 2018. doi:10.1124/pr.117.014381. PMID 29487083.

surrey.ac.uk

epubs.surrey.ac.uk

"Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders" (PDF). Sleep Medicine Reviews. 34: 10-22. August 2017. doi:10.1016/j.smrv.2016.06.005. PMID 28648359. 25 Şubat 2021 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 19 Eylül 2023.

web.archive.org

"Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders" (PDF). Sleep Medicine Reviews. 34: 10-22. August 2017. doi:10.1016/j.smrv.2016.06.005. PMID 28648359. 25 Şubat 2021 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 19 Eylül 2023.
"Melatonin for treatment of sleep disorders" (PDF). Evidence Report/Technology Assessment No. 108. (Prepared by the University of Alberta Evidence-based Practice Center, Under Contract No. 290-02-0023.) AHRQ Publication No. 05-E002-2. Rockville, MD: Agency for Healthcare Research and Quality. Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services (108): 1-7. November 2004. doi:10.1037/e439412005-001. PMC 4781368 $2. PMID 15635761. 3 Mayıs 2013 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 5 Haziran 2013. KB1 bakım: göster-yazarlar (link)
"Melatonin: Side Effects, Uses, Dosage (Kids/Adults)". Drugs.com. 18 Haziran 2006 tarihinde kaynağından arşivlendi. Erişim tarihi: 9 Ocak 2019.
Circadin: EPAR - Product Information ANNEX I - SUMMARY OF PRODUCT CHARACTERISTICS. European Medicines Agency (EMA). 2 Şubat 2021. EMEA/H/C/000695 - IA/0066. 4 Ekim 2018 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Eylül 2023.
"Slenyto EPAR". European Medicines Agency (EMA). 17 Eylül 2018. 20 Mart 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 31 Mayıs 2020.
"Summary Safety Review – MELATONIN (N-acetyl-5-methoxytryptamine) – Review of the Safety of Melatonin in Children and Adolescents". Government of Canada. Health Canada. 10 Aralık 2015. 13 Haziran 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 9 Ocak 2019.
"Melatonin- Oral". Government of Canada. Health Canada. 28 Ağustos 2018. 1 Nisan 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 9 Ocak 2019.
"Melatonin". www.drugbank.ca. 28 Mart 2009 tarihinde kaynağından arşivlendi. Erişim tarihi: 29 Ocak 2019.